IVT-01: A Personalized functional NMJ system for ALS Modeling and Drug Testing

Dr Xiufang Guo1, Dr Virginia Smith1, Max Jackson2, My Tran1, Michael Thomas1, Aakash Patel1, Eric Lorusso1, Siddharth Nimbalkar1, Yunqing Cai1, Dr Christopher McAleer2, Ying Wang3, Dr Christopher Long2, Dr James Hickman1,2 1NanoScience Technology Center, University Of Central Florida, Orlando, United States, 2Hesperos, Inc., Orlando, United States, 3Department of Biomedical Engineering, Cornell University, Orlando, United States

[1]  N. Wray,et al.  Rare Variant Burden Analysis within Enhancers Identifies CAV1 as an ALS Risk Gene , 2020, Cell reports.

[2]  Philip D. Plowright.  Front , 2019, 2020 Fourth World Conference on Smart Trends in Systems, Security and Sustainability (WorldS4).

[3]  B. Jespersen,et al.  Inhibition of epileptiform activity by neuropeptide Y in brain tissue from drug-resistant temporal lobe epilepsy patients , 2019, Scientific Reports.

[4]  A. Aguilera,et al.  R Loops: From Physiological to Pathological Roles , 2019, Cell.

[5]  S. Rossi,et al.  The S100A4 Transcriptional Inhibitor Niclosamide Reduces Pro-Inflammatory and Migratory Phenotypes of Microglia: Implications for Amyotrophic Lateral Sclerosis , 2019, Cells.

[6]  R. Schreiber,et al.  Niclosamide repurposed for the treatment of inflammatory airway disease. , 2019, JCI insight.

[7]  F. Chédin,et al.  High-resolution, strand-specific R-loop mapping via S9.6-based DNA–RNA immunoprecipitation and high-throughput sequencing , 2019, Nature Protocols.

[8]  A. Al-Chalabi,et al.  Mutations in the Glycosyltransferase Domain of GLT8D1 Are Associated with Familial Amyotrophic Lateral Sclerosis , 2019, Cell reports.

[9]  Tibor,et al.  Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria , 2017, Amyotrophic lateral sclerosis & frontotemporal degeneration.

[10]  D. Neuberg,et al.  Two familial ALS proteins function in prevention/repair of transcription-associated DNA damage , 2016, Proceedings of the National Academy of Sciences.

[11]  Robert Layfield,et al.  Defective recognition of LC3B by mutant SQSTM1/p62 implicates impairment of autophagy as a pathogenic mechanism in ALS-FTLD , 2016, Autophagy.

[12]  M. Kiernan,et al.  Cortical hyperexcitability precedes lower motor neuron dysfunction in ALS , 2015, Clinical Neurophysiology.

[13]  Karim Mekhail,et al.  R-loops highlight the nucleus in ALS , 2015, Nucleus.

[14]  M. Kiernan,et al.  Cortical hyperexcitability may precede the onset of familial amyotrophic lateral sclerosis. , 2008, Brain : a journal of neurology.

[15]  G. Sperk,et al.  The anti‐epileptic actions of neuropeptide Y in the hippocampus are mediated by Y2 and not Y5 receptors , 2005, The European journal of neuroscience.